drugset / Trial / NCT02047175
CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the drug-drug interaction of CKD-346(Telmisartan/S-Amlodipine, Rosuvastatin)
Timeline
- Start
- 2014-02
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Telmisartan/S-Amlodipine | Unknown | 2.5 mg | Oral |
| Subject | Telmisartan/S-Amlodipine | Unknown | 40 mg | Oral |